Atlas Trials

MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers.

Clinical trial NCT02224937 · COMPLETED

Trial details

NCT number
NCT02224937
Sponsor
Zealand University Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solar Skin Damage
Start date
2013-12-01
Primary completion
2014-02-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.